Literature DB >> 3542117

The distribution of calcineurin in rat brain by light and electron microscopic immunohistochemistry and enzyme-immunoassay.

S Goto, Y Matsukado, Y Mihara, N Inoue, E Miyamoto.   

Abstract

Calcineurin is the calcium (divalent cations)-dependent calmodulin-stimulated phosphoprotein phosphatase which is capable of dephosphorylating various substrate proteins. The subcellular and regional distribution of calcineurin in the rat brain has been studied by light and electron microscopic immunohistochemistry using antiserum against calcineurin. Immunoreactivity was observed in many neurons but was not detected in glial cells, such as astrocytes, oligodendrocytes and ependymal cells by the PAP method. Light microscopy demonstrates strong immunoreactivity in neuronal somata and neurites. By electron microscopy, calcineurin immunoreactivity was found to be present in dendrites including postsynaptic densities, somata, spines, axons and terminals. Calcineurin immunoreactivity was present in neurons throughout the brain, but a marked regional variation in strength of the immunoreactivity was observed. The caudatoputamen, hippocampal formation, and substantia nigra were strongly stained. Cerebral and cerebellar neocortex showed moderate immunoreactivity. In substantia nigra and globus pallidus, only neurites were stained, but neuronal somata not. The staining of the substantia nigra was thought to be due to that of the nerve terminals originating from the caudatoputamen, in view of the findings by cerebral hemitransection and electron microscopic immunohistochemistry. We developed an enzyme-immunoassay (EIA) for calcineurin. The sensitivity of the EIA was 1 ng (13 fmol) of calcineurin. We determined the level of calcineurin in various regions of the rat brain. The caudate nucleus, putamen and hippocampal formation showed a high concentration of calcineurin. The results are consistent with those obtained by immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542117     DOI: 10.1016/0006-8993(86)91381-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  38 in total

1.  Effect of the calcineurin inhibitor FK506 on K+-Cl- cotransporter 2 expression in the mouse hippocampus after kainic acid-induced status epilepticus.

Authors:  Hyun Joo Shin; Byeong Tak Jeon; Jungmee Kim; Eun Ae Jeong; Myeung Ju Kim; Dong Hoon Lee; Hyun Joon Kim; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Gu Seob Roh
Journal:  J Neural Transm (Vienna)       Date:  2011-12-11       Impact factor: 3.575

Review 2.  Concerted regulation of protein phosphorylation and dephosphorylation by calmodulin.

Authors:  C B Klee
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

3.  Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders.

Authors:  S Goto; A Hirano; R R Rojas-Corona
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Calcineurin Dysregulation Underlies Spinal Cord Injury-Induced K+ Channel Dysfunction in DRG Neurons.

Authors:  Benjamin M Zemel; Tanziyah Muqeem; Eric V Brown; Miguel Goulão; Mark W Urban; Stephen R Tymanskyj; Angelo C Lepore; Manuel Covarrubias
Journal:  J Neurosci       Date:  2017-07-27       Impact factor: 6.167

5.  Calcineurin in the postnatal striatum of the rat: an immunohistochemical study.

Authors:  S Goto; A Hirano
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

6.  An allosteric model of calmodulin explains differential activation of PP2B and CaMKII.

Authors:  Melanie I Stefan; Stuart J Edelstein; Nicolas Le Novère
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

7.  Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors.

Authors:  Feng Liu; David M Virshup; Angus C Nairn; Paul Greengard
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

8.  Basal and cocaine-induced sex differences in the DARPP-32-mediated signaling pathway.

Authors:  Luyi Zhou; Arbi Nazarian; Wei-Lun Sun; Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

9.  Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Dennisse Gonzalez-Romero; Kristi Green; Giulio Taglialatela; Claudio Soto
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

10.  Ligand depletion in vivo modulates the dynamic range and cooperativity of signal transduction.

Authors:  Stuart J Edelstein; Melanie I Stefan; Nicolas Le Novère
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.